Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Angiogenesis
Published in: Angiogenesis 2/2001

01-06-2001

Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood

Authors: Petra Reusch, Bernhard Barleon, Karin Weindel, Georg Martiny-Baron, Astrid Gödde, Gerhard Siemeister, Dieter Marmé

Published in: Angiogenesis | Issue 2/2001

Login to get access
Metadata
Title
Identification of a soluble form of the angiopoietin receptor TIE-2 released from endothelial cells and present in human blood
Authors
Petra Reusch
Bernhard Barleon
Karin Weindel
Georg Martiny-Baron
Astrid Gödde
Gerhard Siemeister
Dieter Marmé
Publication date
01-06-2001
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 2/2001
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1023/A:1012226627813

Other articles of this Issue 2/2001

Angiogenesis 2/2001 Go to the issue

BookReview

Endothelium in vitro: A review of human vascular endothelial cell lines for blood vessel-related research

OriginalPaper

Improved quantification of angiogenesis in the rat aortic ring assay

ReviewPaper

Ectodomain shedding of VEGF183, a novel isoform of vascular endothelial growth factor, promotes its mitogenic activity in vitro

OriginalPaper

Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo

OriginalPaper

Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors

OriginalPaper

Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits